Particular types of hormonal contraceptives (HCs) and genital tract infections have been independently associated with risk of HIV-1 acquisition. We examined whether immunity in women using injectable depot medroxyprogesterone acetate (DMPA), combined oral contraceptives (COC), or no HCs differs by the presence of cervicovaginal infections. Immune mediators were quantified in cervical swabs from 832 HIV-uninfected reproductive-age Ugandans and Zimbabweans.
Original Source [2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/contribution-cervicovaginal-infections-immunomodulatory-effects-hormonal
[2] http://mbio.asm.org/content/6/5/e00221-15
[3] http://admin.indiaenvironmentportal.org.in/category/author/raina-n-fichorova
[4] http://admin.indiaenvironmentportal.org.in/category/author/pai-lien-chen
[5] http://admin.indiaenvironmentportal.org.in/category/author/charles-s-morrison-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/mbio
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aids
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diseases
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/contraception
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-effects
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/uganda
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/zimbabwe
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
